ClinicalTrials.gg
Not yet recruitingNCT06372366Updated Dec 2, 2025

Oral Manifestations in Egyptian Children With Short Stature

An observational study in Oral Manifestations and Short Stature, sponsored by Cairo University. Not yet recruiting. Open to participants aged 6 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-02.

Sponsored by Cairo University · Observational

From the registry’s dates

  • Primary completion was expected by Mar 2026, 7 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
2
Ages
6 Years to 12 Years
Sex
All
01

Study summary

Children with short stature have been reported to show a higher prevalence of enamel hypoplasia, delayed tooth eruption, and malocclusion compared to children of normal growth status

Read the detailed description

Normal growth is a process in which a single cell develops into a fully grown adult. The growth rate decelerates from the embryonic stage to adulthood, except during puberty. Most adults fall within a narrow range of stature, typically between 1.5 to 2 meters. Variations in height among children are largely determined by a set of genes inherited from their parents. These genes influence stature distribution within the normal range for nearly 95% of the population, with variation generally being benign.

Short stature in children-defined as a height-for-age below -2 standard deviations (SD) from the WHO growth reference-typically corresponding to the 2.3rd percentile, though many texts use the 3rd percentile as the cutoff. Short stature can be assessed using various anthropometric instruments. The condition may be physiological, with no abnormalities other than stature (polygenic short stature), or pathological, resulting from systemic illnesses, nutritional deficiencies, psychosocial factors, hormonal imbalances, genetic disorders, or musculoskeletal pathologies. A subset of infants born small for gestational age (SGA) may be at risk of persistent short stature.

Children with short stature have been reported to show a higher prevalence of enamel hypoplasia, delayed tooth eruption, and malocclusion compared to children of normal growth status . These oral manifestations may result from shared pathogenic mechanisms, such as nutritional deficits, systemic disturbances during enamel formation, or hormonal imbalances affecting growth and development. A clearer understanding of these associations may enhance multidisciplinary screening and care.

This study aims to investigate the prevalence and characteristics of oral manifestations in Egyptian children with short stature, contributing to the limited regional data on this topic.

02

Conditions studied

  • Oral Manifestations
  • Short Stature
03

In context

Oral Manifestations

26 studies on the registry are indexed under Oral Manifestations; 3 are open to participants now.

This study's planned enrollment of 2 is below the median of 225 across 15 observational studies indexed under Oral Manifestations.

Browse Oral Manifestations studies →

Lead sponsor

Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Children aged from 6 to 12 years attending National Nutrition Institute will be included in the study according to the following criteria:

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

      • Egyptian children aged 6-12 years.
  • - Diagnosed with short stature (height-for-age \< -2 SD based on WHO standards).
  • - Diagnosed and confirmed by a pediatric endocrinologist.

Controls:

  • - Age- and sex-matched children with normal height (height-for-age between -1 and +1 SD).
  • - Recruited from the same geographic and socioeconomic backgrounds.

Exclusion criteria

Exclusion Criteria:

  • 1- Presence of syndromic conditions (e.g., Turner syndrome, Down syndrome).
  • 2- Chronic diseases (e.g., renal, cardiac, or endocrine conditions other than idiopathic short stature).
  • 3- Long-term medication use known to affect growth or oral development.
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
2 participants (estimated)
Patient registry
No

Groups and cohorts

  • 17children with short stature
  • 17 normal children
06

What researchers measure

Primary outcomes

  1. Dental enamel defects

    using Aine's classification

    Time frame: 3 months

  2. Delayed dental eruption

    using Dental eruption table

    Time frame: 3 months

  3. Malocclusion

    using Angle classification

    Time frame: 3 months

  4. Dental caries experience

    using def+DMF

    Time frame: 3 months

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 2, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06372366
Lead sponsor
Cairo University
Responsible party
Nada Soliman Abd El-Ghaffar Abd El-Megid Abd Allah (Principal researcher (Dentist), Cairo University) — Principal investigator
First posted
Apr 18, 2024
Start date
Dec 15, 2025 (estimated)
Primary completion
Mar 15, 2026 (estimated)
Completion
Apr 15, 2026 (estimated)
Last update
Dec 2, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion